M. S. Sutherland

ORCID: 0009-0002-7005-0604
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Astrophysics and Cosmic Phenomena
  • Platelet Disorders and Treatments
  • Dark Matter and Cosmic Phenomena
  • Blood groups and transfusion
  • Particle Detector Development and Performance
  • Particle physics theoretical and experimental studies
  • Neutrino Physics Research
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Radio Astronomy Observations and Technology

Manchester University NHS Foundation Trust
2024

Louisiana State University
2011

Manchester Royal Infirmary
2009

This guideline updates the previous guidelines1, 2 published on behalf of British Society for Haematology (BSH) and United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO), focussing laboratory components diagnosis monitoring. Clinical aspects will be addressed in a separate guideline. was compiled according to BSH process at https://b-s-h.org.uk/media/16732/bsh-guidance-development-process-dec-5-18.pdf. The writing group, which comprised selected members Haemostasis Thrombosis Task...

10.1111/bjh.19385 article EN British Journal of Haematology 2024-03-26

Type 3 von Willebrand disease (VWD) is a severe autosomal recessive inherited bleeding disorder. In affected individuals the underlying factor gene (VWF) mutations frequently remain uncharacterized. The aim of this study was to investigate molecular basis type VWD in patients (11 Caucasians and 9 Asian origin) attending haemophilia centres at Central Manchester NHS Trust. A combination DNA sequencing VWF genomic complementary performed identify patient cohort. Fifteen different were...

10.1111/j.1365-2516.2009.02059.x article EN Haemophilia 2009-07-10
Coming Soon ...